Sung Ji Nam
Stock Analyst
(n/a)
# 4,648
Out of 4,648 analysts
55
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Sung Ji Nam
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Maintains: Sector Outperform | $83 → $88 | $75.31 | +16.85% | 1 | Oct 31, 2024 | |
| CSTL Castle Biosciences | Maintains: Buy | $35 → $40 | $33.15 | +20.66% | 4 | Oct 14, 2024 | |
| BDSX Biodesix | Initiates: Sector Outperform | $3 | $1.30 | +130.77% | 1 | Sep 16, 2024 | |
| PACB Pacific Biosciences of California | Maintains: Sector Outperform | $8 → $7 | $2.44 | +186.89% | 3 | Aug 28, 2024 | |
| BNGO Bionano Genomics | Downgrades: Sector Perform | $6 → $1 | $0.28 | +254.74% | 5 | Aug 28, 2024 | |
| CDNA CareDx | Upgrades: Buy | $40 | $22.64 | +76.68% | 3 | Aug 19, 2024 | |
| ILMN Illumina | Maintains: Sector Outperform | $176 → $164 | $149.76 | +9.51% | 9 | Aug 15, 2024 | |
| MYGN Myriad Genetics | Maintains: Sector Outperform | $29 → $34 | $17.99 | +88.99% | 2 | Aug 13, 2024 | |
| EXAS Exact Sciences | Initiates: Sector Outperform | $70 | $69.80 | +0.29% | 1 | Jun 27, 2024 | |
| TWST Twist Bioscience | Maintains: Sector Outperform | $43 → $48 | $41.57 | +15.47% | 3 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $7.06 | -15.01% | 2 | Jun 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $36 | $23.00 | +56.52% | 3 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $33 | $34.31 | -3.82% | 3 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $15 | $5.31 | +182.49% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $718 | $557.92 | +28.69% | 11 | Feb 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $21.61 | - | 3 | Nov 24, 2020 |
Bio-Techne
Oct 31, 2024
Maintains: Sector Outperform
Price Target: $83 → $88
Current: $75.31
Upside: +16.85%
Castle Biosciences
Oct 14, 2024
Maintains: Buy
Price Target: $35 → $40
Current: $33.15
Upside: +20.66%
Biodesix
Sep 16, 2024
Initiates: Sector Outperform
Price Target: $3
Current: $1.30
Upside: +130.77%
Pacific Biosciences of California
Aug 28, 2024
Maintains: Sector Outperform
Price Target: $8 → $7
Current: $2.44
Upside: +186.89%
Bionano Genomics
Aug 28, 2024
Downgrades: Sector Perform
Price Target: $6 → $1
Current: $0.28
Upside: +254.74%
CareDx
Aug 19, 2024
Upgrades: Buy
Price Target: $40
Current: $22.64
Upside: +76.68%
Illumina
Aug 15, 2024
Maintains: Sector Outperform
Price Target: $176 → $164
Current: $149.76
Upside: +9.51%
Myriad Genetics
Aug 13, 2024
Maintains: Sector Outperform
Price Target: $29 → $34
Current: $17.99
Upside: +88.99%
Exact Sciences
Jun 27, 2024
Initiates: Sector Outperform
Price Target: $70
Current: $69.80
Upside: +0.29%
Twist Bioscience
May 6, 2024
Maintains: Sector Outperform
Price Target: $43 → $48
Current: $41.57
Upside: +15.47%
Jun 29, 2023
Assumes: Buy
Price Target: $6
Current: $7.06
Upside: -15.01%
Jan 5, 2023
Initiates: Sector Outperform
Price Target: $36
Current: $23.00
Upside: +56.52%
Jan 5, 2023
Initiates: Sector Outperform
Price Target: $33
Current: $34.31
Upside: -3.82%
Jan 5, 2023
Initiates: Sector Outperform
Price Target: $15
Current: $5.31
Upside: +182.49%
Feb 2, 2022
Maintains: Buy
Price Target: $718
Current: $557.92
Upside: +28.69%
Nov 24, 2020
Downgrades: Neutral
Price Target: n/a
Current: $21.61
Upside: -